(Press-News.org) Oncotarget recently published "Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors" by Mortensen, et al. which reported that there is a growing interest in the antibody-based delivery of cytokines to the tumor environment as a means to boost the anti-cancer activity of tumor-resident T cells and NK cells.
Here, the authors described the expression and characterization of fusion proteins, featuring the L19 antibody and an engineered cytokine with interleukin-2 and interleukin-15 properties.
The cytokine moiety was fused either at the N-terminal or at the C-terminal extremity and both fusion proteins showed a selective tumor accumulation in a quantitative biodistribution experiment.
The N-terminal fusion inhibited tumor growth in immunocompetent mice bearing F9 carcinomas or WEHI-164 sarcomas when used as a single agent.
These results indicate that the antibody-based delivery of engineered cytokines to the tumor neovasculature may mediate a potent anticancer activity.
Dr. Michael R. Mortensen from The Department of Chemistry and Applied Biosciences (D-CHAB) at The Institute for Pharmaceutical Sciences (IPW) in Zurich, Switzerland said, "Cancer immunotherapy relies on the activation of certain leukocytes (most typically, T cells and/or natural killer cells), with the aim to induce a selective biocidal activity against tumor cells."
IL2 muteins may alter the interaction of the cytokine with one or more of the IL2 receptor subunits, thus altering the selectivity towards the intermediate affinity receptor or towards the high-affinity receptor.
Since regulatory T cells predominantly express the high-affinity receptor, the selective activation of the intermediate affinity receptor has attracted considerable research efforts.
In a second approach, an increased selectivity towards the intermediate affinity IL2 receptor was achieved by blocking the interaction with CD25 either through IL2 mutations or by antibody blockade of the IL2 epitope involved in CD25 binding.
The Oncotarget authors described a series of engineered cytokines, which displayed biological features intermediate between those of IL2 and of IL15. IL15 interacts with CD122 and CD132 like IL2 but recognizes a different alpha subunit.
One of the new computationally designed cytokine variants, termed by the authors Neoleukin™-2/15, exhibited an increased affinity towards the receptor components shared by IL2 and IL15, with a complete absence of CD25 binding. Moreover, the newly engineered cytokine was much more stable compared to wild-type IL2.
The Mortensen Research Team concluded in their Oncotarget Research Paper that for certain cytokines the fusion with a tumor-homing antibody allows the creation of novel biopharmaceuticals, which display a preferential uptake in tumor lesions and which perform substantially better than the corresponding nontargeted cytokine in immunocompetent mouse models.
These authors and others have reported that not all cytokine payloads can be efficiently delivered to the tumor by fusion with antibodies.
Cytokine trapping at a low dose has been reported for fusion proteins based on interferon-gamma, but also for IL15 fusions.
Neo™-L19 is not glycosylated and the authors were pleased to see how the L19-based targeted delivery of the engineered IL2 and IL15 mimic led to an improved therapeutic effect for the F9 teratocarcinoma model. The contribution of L19-based targeting to an increased therapeutic index was less striking in the WEHI-164 model.
Collectively, the results presented indicate that a new fusion protein could be created, which displayed an excellent performance in biodistribution studies and which mediated a potent anticancer activity in two immunocompetent mouse models of cancer when used as a single agent.
The results suggest that this product, or similar fusion proteins featuring an N-terminal fusion in the diabody format, may deserve to be investigated in clinical trials.
Sign up for free Altmetric alerts about this article
DOI - https://doi.org/10.18632/oncotarget.27772
Full text - https://www.oncotarget.com/article/27772/text/
Correspondence to - Michael R. Mortensen - michael.mortensen@pharma.ethz.ch
Keywords - immunotherapy, immunocytokines, EDB of fibronectin, antibody-cytokine fusion proteins, engineered cytokine
About Oncotarget
Oncotarget is a biweekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105
INFORMATION:
Oncotarget recently published "AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity" which reported that the authors investigated the expression and net effect of the individual isoforms in triple negative breast cancers and response to cisplatin treatment using cellular, mice models and clinical samples.
Interestingly, analysis of the expressions of AKT isoforms in clinical samples showed relatively higher expression of AKT1 in primary tissues; whereas lung and liver metastatic samples showed elevated ...
Coffee, cola or an energy drink: caffeine is the world's most widely consumed psychoactive substance. Researchers from the University of Basel have now shown in a study that regular caffeine intake can change the gray matter of the brain. However, the effect appears to be temporary.
No question - caffeine helps most of us to feel more alert. However, it can disrupt our sleep if consumed in the evening. Sleep deprivation can in turn affect the gray matter of the brain, as previous studies have shown. So can regular caffeine consumption affect brain structure due to poor sleep? A research team led by Dr. Carolin Reichert and Professor Christian Cajochen of the University of Basel ...
Here is a link to watch a video interview with Dr. Beatrice Aramini about this topic on the Oncotarget YouTube Channel
Oncotarget published "Cancer stem cells and macrophages: molecular connections and future perspectives against cancer" which reported that Cancer stem cells have been considered the key drivers of cancer initiation and progression due to their unlimited self-renewal capacity and their ability to induce tumor formation.
Macrophages, particularly tumor-associated macrophages, establish a tumor microenvironment to protect and induce CSCs development and dissemination.
Many studies in the past decade have been performed to understand the molecular ...
For the first time, physicists from the University of Basel have produced a graphene compound consisting of carbon atoms and a small number of nitrogen atoms in a regular grid of hexagons and triangles. This honeycomb-structured "kagome lattice" behaves as a semiconductor and may also have unusual electrical properties. In the future, it could potentially be used in electronic sensors or quantum computers.
Researchers around the world are searching for new synthetic materials with special properties such as superconductivity -- that is, the conduction of electric current without resistance. These new substances are an important step in the development ...
Climate change is rapid in the Arctic. As the climate warms, shrubs expand towards higher latitudes and altitudes. Researcher Julia Kemppinen together with her colleagues investigated the impacts of dwarf shrubs on tundra soils in the sub-Arctic Fennoscandia.
The study revealed that the dominance of dwarf shrubs impacts soil microclimate and carbon stocks. Microclimate describes the moisture and temperature conditions close to ground surface. Shrubs are the largest plant life form in the Arctic, and in comparison, to other arctic plants, shrubs use more water and cast more shade.
"The results indicate ...
WASHINGTON -- When people pause before replying to a question, even for just a few seconds, their answers are perceived to be less sincere and credible than if they had replied immediately, according to research published by the American Psychological Association.
And the longer the hesitation, the less sincere the response appears.
"Evaluating other people's sincerity is a ubiquitous and important part of social interactions," said lead author Ignazio Ziano, PhD, of Grenoble Ecole de Management. "Our research shows that response speed is an important cue on which people base their sincerity inferences."
The research was published in the Journal of Personality and Social Psychology.
Researchers ...
Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of tumor selectivity of conventional treatments.
Scientists at Japan Advanced Institute of Science and Technology (JAIST) have created a photosynthetic bacteria-based cancer optotheranostics (Figure 1).
Discovered by Associate Professor Eijiro Miyako and his team from JAIST, natural purple photosynthetic bacteria (PPSB) can play a key role as a highly active cancer immunotheranostics agent that uses the bio-optical-window I and II near-infrared (NIR) light thanks to the light harvesting nanocomplexes in microbial ...
There is no coat colour that distinguishes dingoes from dingo-dog hybrids, a study involving UNSW Sydney has found.
The Centre for Ecosystem Science research suggests that animals assumed to be dingo-dog hybrids based on their coat colour and culled may have been pure dingoes.
"We actually found pure dingoes that had a brindle, black and tan, patchy or sable coat colour," Dr Kylie Cairns, a conservation biologist from UNSW Sydney and co-author of the study said.
"So that's showing that really dingoes are much more variable than we think and seeing an animal with an odd coat colour doesn't immediately mean that it's a hybrid.
"Using coat colour to decide what animals should be culled is not a very good idea."
The study follows 2019 research by UNSW and collaborators which found ...
San Antonio, Texas (February 15, 2020) - Researchers at the Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) may have found a new pathway to treat and control tuberculosis (TB), the disease caused by Mycobacterium tuberculosis (Mtb). Using single-cell RNA sequencing (scRNAseq), a next-generation sequencing technology, scientists were able to further define the mechanisms that lead to TB infection and latency. Co-led by Deepak Kaushal, Ph.D., Director of the SNPRC, this is the first study that used scRNAseq to study TB in macaques in depth. Results from the study were published ...
Scientists of Kemerovo State University, within the framework of the Russian Scientific Foundation grant "Cultivation of isolated cells and organs of rare and endemic medicinal plants of Siberia and the Far East in vitro as a biotechnological method for obtaining biologically active substances", are investigating the fundamental principles of in vitro cultivation of isolated cells and organs of rare medicinal plants - producers of biologically active substances with cytotoxic, antioxidant and antimicrobial properties. One of the urgent problems of medicine and biology is the search and use of plant objects as medicines. The unfavorable environmental situation and the increasing need for medicinal raw materials create its shortage. A new solution ...
